BE666424A - - Google Patents
Info
- Publication number
- BE666424A BE666424A BE666424DA BE666424A BE 666424 A BE666424 A BE 666424A BE 666424D A BE666424D A BE 666424DA BE 666424 A BE666424 A BE 666424A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2813865 | 1965-05-12 | ||
| JP2834265 | 1965-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE666424A true BE666424A (en:Method) | 1966-01-05 |
Family
ID=26366189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE666424D BE666424A (en:Method) | 1965-05-12 | 1965-07-05 |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE666424A (en:Method) |
| CH (1) | CH464935A (en:Method) |
| DE (1) | DE1620284C3 (en:Method) |
| FR (1) | FR4491M (en:Method) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9387209B2 (en) * | 2012-04-10 | 2016-07-12 | Annji Pharmaceutical Co., Ltd. | Histone deacetylases (HDACs) inhibitors |
-
1965
- 1965-07-05 BE BE666424D patent/BE666424A/xx unknown
- 1965-07-05 CH CH936465A patent/CH464935A/de unknown
- 1965-07-06 DE DE1620284A patent/DE1620284C3/de not_active Expired
- 1965-07-06 FR FR23661A patent/FR4491M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1620284A1 (de) | 1970-03-12 |
| CH464935A (de) | 1968-11-15 |
| DE1620284B2 (de) | 1974-03-21 |
| FR4491M (en:Method) | 1966-10-10 |
| DE1620284C3 (de) | 1974-10-24 |